2022
DOI: 10.1007/s12274-022-5184-7
|View full text |Cite
|
Sign up to set email alerts
|

Self-assembly of polysarcosine amphiphilic polymers-tethered gold nanoparticles for precise photo-controlled synergistic therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 44 publications
0
8
0
Order By: Relevance
“…The ATP, CRT, and HMGB-1 enzyme-linked immunosorbent assay (ELISA) kits were purchased from Beyotime (Shanghai, China). Sar-NCA was synthesized according to our previous report . All other biochemical reagents were purchased from Sigma-Aldrich and used without any other purification process.…”
Section: Materials and Experimental Proceduresmentioning
confidence: 99%
See 3 more Smart Citations
“…The ATP, CRT, and HMGB-1 enzyme-linked immunosorbent assay (ELISA) kits were purchased from Beyotime (Shanghai, China). Sar-NCA was synthesized according to our previous report . All other biochemical reagents were purchased from Sigma-Aldrich and used without any other purification process.…”
Section: Materials and Experimental Proceduresmentioning
confidence: 99%
“…Sar-NCA was synthesized according to our previous report. 26 All other biochemical reagents were purchased from Sigma-Aldrich and used without any other purification process. All animal experiments were carried out in accordance with ethical regulations and were approved by the Animal Experimentation Facility of the Chinese University of Pharmacy and Pharmaceutical Sciences.…”
Section: Materials and Experimental Proceduresmentioning
confidence: 99%
See 2 more Smart Citations
“…In general, various strategies have been proposed in designing light-stimulated drug release systems for tumor therapy: (1) absorption of light dissociating the prodrug into its active form; (2) absorption of light by a photosensitive molecule, which triggers a physical change that releases the encapsulated drug [67,68]. The former commonly involves functionalizing the chemotherapeutic drug to obtain a prodrug with reduced cytotoxicity.…”
Section: Light-responsive Nanocarriersmentioning
confidence: 99%